Ana Alvarez-Requejo
- Toxicology top 0.5%
- Pediatrics, Perinatology and Child Health top 10%
- Public Health, Environmental and Occupational Health
- Pharmacology
- Pharmacology top 10%
- Co-authors
- Bernard BégaudYola MorideAlfonso CarvajalLuis H. Martín AriasFrançoise HaramburuTomás VegaIsaac Martín de DiegoJavier García del Pozo
- Topics
- Pharmacovigilance and Adverse Drug Reactions (3 papers)Drug-Induced Hepatotoxicity and Protection (2 papers)Opioid Use Disorder Treatment (2 papers)
In The Last Decade
Ana Alvarez-Requejo
13 papers receiving 527 citations
Peers
Comparison fields: 5 of 90
- Toxicology 247
- Pediatrics, Perinatology and Child Health 130
- Public Health, Environmental and Occupational Health 110
- Pharmacology 90
- Pharmacology 79
Countries citing papers authored by Ana Alvarez-Requejo
This map shows the geographic impact of Ana Alvarez-Requejo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Alvarez-Requejo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Alvarez-Requejo more than expected).
Fields of papers citing papers by Ana Alvarez-Requejo
This network shows the impact of papers produced by Ana Alvarez-Requejo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Alvarez-Requejo. The network helps show where Ana Alvarez-Requejo may publish in the future.
Co-authorship network of co-authors of Ana Alvarez-Requejo
This figure shows the co-authorship network connecting the top 25 collaborators of Ana Alvarez-Requejo. A scholar is included among the top collaborators of Ana Alvarez-Requejo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana Alvarez-Requejo. Ana Alvarez-Requejo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 40 | |
| 2 | 23 | |
| 3 | [Potential to predict the risk of developing proliferative vitreoretinopathy with the analysis of clinical factors of regmatogenous retinal detachments]. | 3 |
| 4 | 4 | |
| 5 | [Anti-ulcer drug consumption in Spain]. | 3 |
| 6 | 195 | |
| 7 | 148 | |
| 8 | 124 | |
| 9 | [Changes in the pattern of opioid analgesic consumption in Spain]. | 4 |
| 10 | 15 | |
| 11 | Vacuna DTP y sindrome de muerte subita del lactante: un metaanalisis [The DTP vaccine and the infant sudden death syndrome: meta-analysis] | 1 |
| 12 | [DTP vaccine and infant sudden death syndrome. Meta-analysis]. | 7 |
| 13 | 9 |
About Ana Alvarez-Requejo
Ana Alvarez-Requejo is a scholar working on Toxicology, Pharmacology and Microbiology, having authored 13 papers that have together received 576 indexed citations. Recurring topics across this work include Pharmacovigilance and Adverse Drug Reactions (3 papers), Drug-Induced Hepatotoxicity and Protection (2 papers) and Opioid Use Disorder Treatment (2 papers). The work is most often cited by research in Toxicology (247 citations), Geriatrics and Gerontology (75 citations) and Pharmacology (79 citations). Ana Alvarez-Requejo has collaborated with scholars based in Spain and France. Frequent co-authors include Bernard Bégaud, Yola Moride, Alfonso Carvajal, Luis H. Martín Arias, Françoise Haramburu, Tomás Vega, Isaac Martín de Diego, Javier García del Pozo, Mikhail Benet Rodríguez and Miquel Porta. Their work appears in journals such as Journal of Clinical Epidemiology, British Journal of Clinical Pharmacology and Drug Safety.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.